Background and Purpose.-To evaluate the association between cumulative exposure to migraine and incidence of ischemic stroke in the Atherosclerosis Risk in Communities (ARIC) study.
INTRODUCTION
Migraine is a chronic neurological disorder with episodic headaches which usually start earlier in life. Migraine, especially migraine with aura (MA), is associated with increased risk of ischemic stroke, [1] [2] [3] and higher risk of stroke in migraineurs younger than 45 years of age. 4 The risk of stroke is higher with a higher frequency of migraine in young women. 5 Furthermore, right-to-left cardiac shunts and a procoagulant state are associated with MA in a young stroke population. 6 Increased migraine has been associated with more widespread functional and morphological abnormalities in the brain. [7] [8] [9] The rate of cardiovascular diseases (CVD) in migraineurs increases with age in both men and women in a US population study. 10 However, it remains unclear if the higher risk of CVD is related to the exposure to migraine at an earlier age or is associated with aging-related CVD risk. Understanding of the association between the age of onset of migraine and ischemic stroke in late life may shed light on the effect of migraine on cerebrovascular disease. We hypothesized that longer cumulative exposure to migraine, as would be expected with early onset of migraine, is associated with an increased risk of ischemic stroke in late life. We proposed to investigate the association between patients with MA and migraine without aura (MO) whose onset was before, at and after age 50, and their risk of ischemic stroke in late life.
MATERIALS AND METHODS
The data that support the findings of this study are available with the ARIC committee and can be requested from the ARIC steering committee.
Participants and Procedures.-The cohort of the ARIC study was initiated in 1987 with the aim of studying the causes and clinical sequelae of atherosclerosis. 11 Fifteen thousand nine hundred and seventy-two participants from 4 different counties in the US (Washington County, MD; Forsyth County, NC; Jackson, MS; and Minneapolis, MN) were recruited from 1987 to 1989 in this ongoing, prospective longitudinal community-based study. The participants were interviewed to ascertain migraine history at the third in-person visit (1993-1995) and followed for ischemic stroke incidence over 20 years. In addition to clinic visits, all the participants were contacted by telephone, initially annually and more recently semi-annually, to ascertain any interim hospitalizations. We included all black and white participants by excluding Asians and Hispanics (n = 46) who completed the third clinic visit (1993) (1994) (1995) in the ARIC (n = 12,836). Any participant with no headache information (n = 37), participants with stroke events before the third visit (n = 87), and participants with nonmigraine headache (n = 1082) were excluded. There are 38 migraine participants with no age of onset of headache and hence were excluded from the analysis (9 of them had migraine with aura). A total of 11,592 participants fulfilled our criteria and were included for analysis. Standard Protocol Approvals, Registrations, and Patient Consents.-The institutional review boards of all participating institutions approved the study, and all participants provided written informed consent.
Assessment of Migraine.-A headache questionnaire was administered to all the participants who attended the ARIC visit 3. Based on the results from this questionnaire, modified International Classification of Headache Disorders (ICHD III beta) diagnostic criteria were used to characterize migraine with visual aura and migraine without visual aura. Participants were classified as having migraine if they endorsed headaches lasting at least 4 hours or longer in duration, with throbbing or pulsating pain, and if headaches were mostly on one side; headaches must have also been accompanied by photophobia and phonophobia or nausea or vomiting. This information was all identified from the headache questionnaire used in visit 3. In addition, headache was separated into migraine with visual aura if the participant reported seeing spots, jagged lines, or heat waves in one or both eyes before onset of headache. All other migraine headaches that did not qualify for migraine with visual aura were classified as migraine without visual aura. All other headaches that lasted for more than 4 hours and did not qualify for migraine headache were classified as nonmigraine headaches and those individuals who did not report a history of headaches greater than 4 hours were classified into the no headache group. Individuals with nonmigraine headaches were excluded from the analysis.
The age of migraine onset was determined by subtracting the number of years of recurrent migraine headaches at the third visit from the age at the third visit based on the questionnaire. MA was further stratified into 2 subgroups: (1) migraine symptoms onset before age 50, and (2) onset at and after age 50 to study the association between the age of onset of MA and the risk of ischemic stroke in late life.
Adjudication of Stroke and Subtypes.-All stroke hospitalizations and deaths from 1987 to 2012 occurring in the ARIC participants were identified. Hospital records for possible strokerelated hospitalizations were obtained (International Classification of Diseases, Ninth Revision [ICD-9] codes 430-438 until 1997 and codes 430-436 afterwards) and stroke deaths were ascertained through linkage with the National Death Index. Physician reviewers adjudicated all possible strokes and classified them as definite or probable ischemic events. 12 Verified incident first ischemic strokes included all the events occurring between the date of visit 3 (1993-1995) and December of 2012; we excluded incident strokes from visit 1 to visit 3 and all self-reported previous strokes at visit 1. Classification required evidence of sudden or rapid onset of focal neurologic symptoms lasting 24 hours or leading to death, in the absence of evidence for a nonstroke cause. Ischemic strokes were further classified according to subtype as thrombotic brain infarction, lacunar infarction, or cardioembolic stroke, according to the criteria adopted from the National Survey of Stroke subtype classification. Neuroimaging patterns of infarct distribution were not considered per the algorithm based on the National Survey of Stroke available at the time of this study initiation. We used the same criteria for stroke subtype adjudication in our previous paper.
Covariates.-Potential confounders were included in the multivariate models generated. We used date of birth to calculate age, and sex and race were self-reported by the participants at the baseline visit. At the third visit, diabetes mellitus was defined as fasting blood glucose equal or greater than 126 mg/dL (or greater than 200 mg/dL if not fasting), self-reported history of physician's diagnosis, or use of diabetes medication. Hypertension was defined as systolic blood pressure equal to 140 mm Hg or higher and diastolic blood pressure equal to 90 mm Hg or higher (average of 2 blood pressure readings at the visit), or self-reported hypertension medication use. Hyperlipidemia is classified if fasting LDL >100 mg/dL, and any smoking history per self-report was considered a positive for smoking. BMI (kg/m 2 ; calculated using height and weight measured at the third visit) >25 was classified as overweight, and BMI >30 as obesity; the number of the hours of physical activity was self-reported at visit 3. Physical activity was considered significant if performed for more than 3 hours/week for at least a month. Regular NSAID use was self-reported at the third clinical visit. Statistical Analysis.-Incidence rates in each subgroup were calculated as the number of events in each migraine subgroup per year per 1000 persons from 1993 to 2012. To study the association between patients with MA/MO and their stroke risk, we used cut-off at age onset before, at and after 50, based on the prevalence of migraine. To further support this clinical decision, we implemented logistic regression by using stroke as the dependent variable and using higher order terms of age at onset of migraine as the independent variables to study the overall stroke risk. We also performed a chi-squared analysis to confirm the stroke risk differences between participants whose migraine onset at age before 50, at and after 50.
Cox proportional hazard model was used first to assess the association between migraineurs (MA and MO) with symptoms onset before 50, at and after 50, and incidence of ischemic stroke as compared to the no headache participants (because Cox proportional hazard model is a nonparametric modeling method with loose assumption constriction, proportion hazard assumption was verified by checking out the log-log plot). Given the low incidence of ischemic stroke over the 20 year follow-up period, we re-analyzed the data using logistic regression instead of fitting the mixed model directly to do longitudinal analysis. This is because too few observations at some time-to-event knots may cause higher false discovery rate and overfitting the curve. Kaplan-Meier analysis was performed to study the survival probability of MA with the age of onset before 50, at or after 50, and the no headache groups. The analysis utilized all available data at the time of analysis, and no a priori statistical power calculation was conducted. However, a HR ≥ 1.5 would be interpreted as clinically significant. All data analyses (2-tailed tests) were performed using SAS version 9.4. A P value of less than .05 was considered significant. Further analysis on stroke subtypes related to migraine status was not done due to low subtype stroke incidence among MA subgroup participants.
RESULTS
The mean age of this study population was 61 years, 76.5% (8872/11,592) of the participants were white, and 55.3% (6417/11,592) were female. In this cohort, migraine was more prevalent in women than in men (about 3:1) in each subgroup investigated. Among the study participants, 13.9% (1613/11,592) had a history of migraine headaches: 447/11,592 (3.85%) migraine with aura and 1128/11,592 (9.7%) migraine without aura. The mean age of migraine symptoms onset in the study population was 37 years old. Table 1 summarizes the demographic characteristics and the distribution of stroke risk factors among each subgroup of participants.
In this cohort, 5.95% (691/11,592) of the participants had an incident ischemic stroke event between the third in-person visit to 2012. Among all migraineurs (MA and MO), 5.26% (86/1,575) of the participants had an incident ischemic stroke event during this time period. The incidence rate of stroke among MA with the age of onset at or after 50 is 6.67 per 1000 person per years, versus 3.04 in MA with the age of onset before 50. Table 2 summarizes the stroke/ subtype of stroke incidence rates.
In our Cox proportional hazard model, the proportional hazard assumption was tested by log-log plot. Based on the log-log plot, the hazard function of MA ≥50 and MA<50 has no interaction which indicates the proportional hazard assumption is appropriate in our study (Fig. 1) . In addition, we found that the chi-squared test P values are less than .05 and the odds ratio (MA ≥50 vs MA <50) is 2.293 (1.205-4.360) (Supplementary Table S2 ). This indicates that the association of MA at or above 50 is a risk for stroke as compared to MA below 50. The higher order logistic regression model demonstrated that stroke risk probability for participants with MA <50 is almost flat and increased very slowly but the stroke risk probability after MA ≥50 became accelerated (Fig. 2) . These findings further support our decision to use MA age of onset 50 as the splitting point in our study.
When compared to the no headache participants, there was a significant association between MA starting at or after age 50 (average duration of symptoms = 4.75 years) and ischemic stroke (age and gender Table 3 summarizes the odds ratios and hazard ratios for ischemic stroke related to migraine status as stratified by the age of the MA symptoms' onset when compared to the no headache participants. Additionally, Figure 3 depicts the Kaplan-Meier survival distributions for ischemic stroke among MA participants at age of onset at or after age 50 and before age 50, as compared to the no headache group.
DISCUSSION
MA is associated with increased ischemic stroke risk in the ARIC. 13 In this post hoc analysis, we found unexpected results suggesting that the onset of MA before age 50 is not associated with ischemic stroke. Specifically, earlier onset of MA with longer MA history (28.17 years) but no prior stroke before enrollment did not pose increased stroke risk in late life. These results are specific to first time ischemic stroke incidents that occurred in mid-to late life; therefore, it cannot be generalized to stroke in younger patients.
It is important to note that the age at the time of diagnosis of migraine as used in many epidemiological studies does not provide adequate information on the duration of migraine. The link between migraine and CVD remained the same in the subgroup of (MA and MO) after adjusting for a comprehensive lists of cardiovascular risk factors in a large population-based Swedish twin study (mean age at the time of enrollment 45.3). 16 Conversely, we found that late onset of MA (age 50 and later) was an independent stroke risk factor, despite the shorter MA history (mean duration = 4.75 years). Taken together, these results suggest that increased stroke risk may not be related to recurrent MA attacks over longer periods, despite the associated aberrant functional and microstructural changes in brain regions. [17] [18] [19] [20] Given that no significant atherosclerosis burden in migraineurs was found when compared to nonmigraineurs, 21, 22 it is unlikely atherosclerosis plays an important role in the shared mechanism between MA and stroke. Clinical and preclinical evidence demonstrates that cortical spreading depression (CSD) is the physiological substrate of MA. 23 As our results suggest that longer exposure to recurrent migraine in older migraineurs is not associated with increased stroke risk, therefore we suspect that recurrent exposure to CSD in those with early onset of MA is not capable of inducing ischemia sufficient for tissue infarct. Interestingly, preconditioning the brain with CSD for 48 hours actually induces tolerance for ischemia using a preclinical animal model. 24 It may be even possible that recurrent MA events precondition the brain and serve as a protective/compensatory response against CNS ischemia in this population studied. Interestingly, MA participants with recent symptoms onset showed significant increased stroke risk, before and after adjusting for multiple conventional cardiovascular risk factors. We hypothesize that there are several reasons for increased ischemic stroke risk in those with late onset of MA. Certainly, cardioembolic stroke may be due to atrial fibrillation, valvular heart disease, post-cardiac procedure as adjudicated in ARIC, but this does not fully explain other stroke events accumulated over 20 years (Table 2) . PFO may play an important role in susceptible migraineurs. 25 Microemboli are capable of inducing CSD. [26] [27] [28] It is plausible MA symptoms occurring at late age is a "red flag" for paradoxical emboli from PFO or microemboli, in addition to cardioembolism, or may be reflective of TIA that is not presented as amaurosis fugax. Taken together, we speculate that the mechanisms underlying MA occurring at different stages in adult life may vary; the degree of CSD required to induce MA symptoms in those with late onset of MA may be different from those with early onset. There may exist a common pathophysiology of increased ischemic stroke risk in young stroke population 6 and older adults with late onset of MA as shown in our study, suggestive of underlying triggers such as microemboli responsible for MA symptoms. Additionally, our results are consistent with previous epidemiological studies, that MO is not a significant risk factor for ischemic stroke, when excluding stroke related to cervical artery dissection. 29 Amaurosis fugax was classified as TIA in ARIC, and therefore was not included in this analysis. Aura characteristics are based on the ARIC databook, documented as "Did you ever notice spots, jagged lines or heat waves in 1 or both eyes before you got the headache." Could this phenomenon be atypical TIA? Amaurosis fugax is traditionally defined as a temporary loss of vision in one or both the eyes (as if a curtain is coming down, darkening, etc) and is considered as a negative symptom. Visual aura is defined as a positive symptom in the ARIC questionnaires.
Women have a higher stroke risk in the decade after menopause (average age 51), which is likely related to conventional cardiovascular risk factors associated with lower estrogen and higher androgen levels during this period.
14,30-32 We do not think this significantly impacted our results, as participants from each subgroup as stratified by age were enrolled at similar ages, despite the differences in the onset of MA symptoms. We have adjusted for age, gender, and other potential confounders; additionally, this prospective study spans over 2 decades. Strengths and Limitations.-This study is unique because the migraine questionnaires used allow us to evaluate the association between the age of MA symptom onset and stroke risk. To our knowledge, it is the first, large prospective study evaluating the relationship between years of exposure to migraine and ischemic stroke. Availability of important covariates in this cohort further strengthened our results.
We do acknowledge some limitations in this study. First, migraine classification used in the ARIC is based on questionnaires, is administered in late midlife, and is therefore subject to recall bias. It is possible that the participants may have recalled more recent migraine better than distant migraine. Additionally, MA symptoms only included visual aura and may have inadvertently excluded migraine with sensory, motor (hemiplegic migraine), or brainstem aura due to the 1993 design of the headache questionnaire. We do not expect this to significantly alter our findings as visual aura is the most common type of aura (80-90%). 33, 34 In addition, the modified ICHD III-beta criteria we used were more stringent and it is possible that we may have classified some migraineurs who presented with bilateral headache or lasted less than 1 year as the no migraine headache group, who were excluded from our analyses. However, we do not expect this to be biased in respect to the association with stroke given nonmigraine headache participants were excluded from our analysis and thus it would not necessarily change the results. Lastly, in this cohort, we do not have data on the frequency of migraine attacks each year; rather, we only have data on the number of years the participants have been experiencing migraine. Therefore, we cannot associate the findings with the frequency of migraine attacks.
SUMMARY
This study underscores the importance of MA symptoms onset in evaluation of ischemic stroke risk in late life. Furthermore, in participants with lifelong MA but no prior stroke, MA is not an independent risk factor for ischemic stroke in late life. Future prospective studies to investigate the link between onset and frequency of exposure to MA and ischemic stroke are warranted.
